Convergent Genomics
Pre-clinicalConvergent Genomics is on a mission to simplify and accelerate cancer diagnostics serving clinicians and patients with personalized data.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $33M
About
Convergent Genomics is on a mission to simplify and accelerate cancer diagnostics serving clinicians and patients with personalized data.
Genetics & Genomics
Funding History
2Total raised:$33M
Series A$25MNov 15, 2022
Seed$8MApr 15, 2021